467 related articles for article (PubMed ID: 20941617)
1. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
[TBL] [Abstract][Full Text] [Related]
6. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
7. Human myeloid dendritic cells are refractory to tryptophan metabolites.
von Bubnoff D; Wilms H; Scheler M; Brenk M; Koch S; Bieber T
Hum Immunol; 2011 Oct; 72(10):791-7. PubMed ID: 21699942
[TBL] [Abstract][Full Text] [Related]
8. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
9. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
Fallarino F; Grohmann U; Puccetti P
Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
[TBL] [Abstract][Full Text] [Related]
11. The immunoregulatory role of IDO-producing human dendritic cells revisited.
Terness P; Chuang JJ; Opelz G
Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
[TBL] [Abstract][Full Text] [Related]
12. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
[TBL] [Abstract][Full Text] [Related]
14. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
15. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
Puccetti P; Fallarino F
Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
[TBL] [Abstract][Full Text] [Related]
16. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T; Danese S; De Cristofaro R; Rutella S
Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
[TBL] [Abstract][Full Text] [Related]
19. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.
Belladonna ML; Grohmann U; Guidetti P; Volpi C; Bianchi R; Fioretti MC; Schwarcz R; Fallarino F; Puccetti P
J Immunol; 2006 Jul; 177(1):130-7. PubMed ID: 16785507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
